会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Lentivirus-based gene transfer vectors
    • 基于慢病毒的基因转移载体
    • US06521457B2
    • 2003-02-18
    • US09900419
    • 2001-07-06
    • John C. Olsen
    • John C. Olsen
    • C12N15867
    • C12N15/86A61K48/00C12N7/00C12N2740/15043C12N2740/15052
    • A recombinant lentiviral vector expression system comprises a first vector that comprises a nucleic acid sequence of at least part of the Equine Infectious Anemia Virus (EIAV) genome. The vector contains at least one defect in at least one gene encoding an EIAV structural protein, but is preferably a gag/pol expression vector. The expression system further comprises a second vector, also comprising a nucleic acid sequence of at least part of the Equine Infectious Anemia Virus (EIAV) genome, and additionally containing a multiple cloning site wherein a heterologous gene may be inserted. The expression system also comprises a third vector which expresses a viral envelope protein. The first and third vectors are packaging signal-defective. When the expression system is transfected into a lentivirus-permissive cell, replication-defective EIAV particles may be produced, which particles are useful in delivering heterologous genes to a broad range of both dividing and non-dividing cells.
    • 重组慢病毒载体表达系统包含第一载体,其包含至少部分马传染性贫血病毒(EIAV)基因组的核酸序列。 该载体在编码EIAV结构蛋白的至少一个基因中含有至少一个缺陷,但优选为gag / pol表达载体。 表达系统还包含第二载体,其还包含至少部分马传染性贫血病毒(EIAV)基因组的核酸序列,并另外含有可以插入异源基因的多克隆位点。 表达系统还包含表达病毒包膜蛋白的第三载体。 第一和第三载体是包装信号有缺陷的。 当将表达系统转染入慢病毒允许细胞时,可以产生复制缺陷型EIAV颗粒,该颗粒可用于将异源基因递送到分裂细胞和非分裂细胞的广泛范围。
    • 3. 发明授权
    • Lentivirus-based gene transfer vectors
    • 基于慢病毒的基因转移载体
    • US06277633B1
    • 2001-08-21
    • US09076707
    • 1998-05-12
    • John C. Olsen
    • John C. Olsen
    • C12N1509
    • C12N15/86A61K48/00C12N7/00C12N2740/15043C12N2740/15052
    • A recombinant lentiviral vector expression system comprises a first vector that comprises a nucleic acid sequence of at least part of the Equine Infectious Anemia Virus (EIAV) genome. The vector contains at least one defect in at least one gene encoding an EIAV structural protein, but is preferably a gaglpol expression vector. The expression system further comprises a second vector, also comprising a nucleic acid sequence of at least part of the Equine Infectious Anemia Virus (EIAV) genome, and additionally containing a multiple cloning site wherein a heterologous gene may be inserted. The expression system also comprises a third vector which expresses a viral envelope protein. The first and third vectors are packaging signal-defective. When the expression system is transfected into a lentivirus-permissive cell, replication-defective EIAV particles may be produced, which particles are useful in delivering heterologous genes to a broad range of both dividing and non-dividing cells.
    • 重组慢病毒载体表达系统包含第一载体,其包含至少部分马传染性贫血病毒(EIAV)基因组的核酸序列。 该载体在编码EIAV结构蛋白的至少一个基因中含有至少一个缺陷,但优选为gaglpol表达载体。 表达系统还包含第二载体,其还包含至少部分马传染性贫血病毒(EIAV)基因组的核酸序列,并另外含有可以插入异源基因的多克隆位点。 表达系统还包含表达病毒包膜蛋白的第三载体。 第一和第三载体是包装信号有缺陷的。 当将表达系统转染入慢病毒允许细胞时,可以产生复制缺陷型EIAV颗粒,该颗粒可用于将异源基因递送到分裂细胞和非分裂细胞的广泛范围。